Search
Powered By HealthLine
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Some Blood Pressure Drugs Boost Diabetes Risk

Treatment should be tailored to individual patients, experts say

By Steven Reinberg
HealthDay Reporter


Related Encyclopedia
 border=
Addison's Disease
Alzheimer's Disease
Aneurysms
Angina Pectoris
More...

Related Healthscout Videos
 border=
Hope for Diabetes and Lou Gehrig's
Howard: The Helping Hand for Stroke Survivors
Fixing Torn Hearts
Medicine's Next Big Thing? Growing Hearts
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Angioplasty
Animation: What is Hypertension?
Coronary Bypass Surgery
More...

Related Drug Information
 border=
Accupril
Actonel
Actos
Altace
More...

Related News Articles
 border=
Statin Therapy Helps Diabetic Patients
Vitamin C May Play Role in Stroke Prevention
Too Much Sugar-Free Gum Linked to Severe Weight Loss
Priming Heart Before an Attack Could Limit Damage
More...

THURSDAY, Jan. 18 (HealthDay News) -- Some common blood pressure drugs can substantially increase the risk of diabetes, especially among those already at risk for the condition, U.S. researchers report.

According to the report, angiotensin-receptor blockers (ARBs) and angiotensin-converting-enzyme (ACE) inhibitors are the blood pressure drugs least associated with diabetes. These are followed by calcium-channel blockers.

Text Continues Below



Beta blockers and diuretics are the drugs most associated with the condition.

"There are differences across the various types of drugs that we use to treat high blood pressure in people who develop diabetes," said study author Dr. William Elliott, from the department of preventive medicine at Rush University Medical Center, Chicago.

The report is published in the Jan. 20 issue of The Lancet.

In the study, Elliott and his colleague Peter Meyer looked at 22 clinical trials that included more than 143,000 people. These people had high blood pressure but did not have diabetes at the start of the trials. In each trial, the participants received long-term treatment with each class of blood pressure drugs or placebo.

The traditional medicines used to treat high blood pressure in the United States are diuretics and beta blockers, Elliott said. "It so happens that they are the two drug classes that are most likely to precipitate diabetes. It turns out the two of the new classes of drugs -- ACE inhibitors and ARBs -- are the two that have the least amount of diabetes associated with them. In the middle, we have calcium-channel blockers," he said.

Elliott noted that your risk of getting diabetes while taking diuretics and beta blockers depends on a number of factors. These include how long you are on the medication, your weight, your family history of diabetes, whether or not you have recently gained weight, and other risk factors, he said.

Page:  1 | 2 | 3 | Next >>

Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 1/18/2007

Related Links
 border=
From Healthscout's partner site on high blood pressure, HighBloodPressureConnection.com
Learn more about high blood pressure symptoms.
Have high blood pressure? Learn about blood pressure medications.
Ways to lower blood pressure





New Features

New ADHD Site!

SOURCES: William Elliott, M.D., Ph.D., Department of Preventive Medicine, Rush University Medical Center, Chicago; Stuart Weiss, M.D., endocrinologist, New York University Medical Center, and clinical assistant professor, NYU School of Medicine, New York City; Byron K. Lee M.D., assistant professor, medicine, University of California, San Francisco, Division of Cardiology; Jan. 20, 2007, The Lancet; Jan. 19, 2007, British Medical Journal


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map